Jyotsna Ghai - 02 Nov 2023 Form 3 Insider Report for Singular Genomics Systems, Inc.

Role
Chief Operating Officer
Signature
/s/ Dalen Meeter, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
02 Nov 2023
Net transactions value
$0
Form type
3
Filing time
09 Nov 2023, 17:30:26 UTC
Next filing
13 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding OMIC Common Stock 3,000 02 Nov 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OMIC Employee Stock Option (Right to Buy) 02 Nov 2023 Common Stock 400,000 $0.3600 Direct F1
holding OMIC Restricted Stock Unit 02 Nov 2023 Common Stock 200,000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the the option shares vest and become exercisable on October 2, 2024, the remainder of the option shares vest in 36 equal monthly installments thereafter, beginning on November 2, 2024.
F2 25% of the Restricted Stock Units vest on October 2, 2024, the remainder of the Restricted Stock Units vest in 12 equal quarterly installments thereafter, beginning on January 2, 2025.
F3 Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's Common Stock.

Remarks:

Exhibit 24 - Power of Attorney